QS Investors’s Immunomedics Inc IMMU Stock Holding History

QS Investors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,510	Closed	-$160K	–	1654
2020 Q2	$160K	Hold	4,510	–	–	﹤0.01%	1195
2020 Q1	$61K	Hold	4,510	–	–	﹤0.01%	1373
2019 Q4	$92K	Hold	4,510	–	–	﹤0.01%	1409
2019 Q3	$60K	Hold	4,510	–	–	﹤0.01%	1461
2019 Q2	$63K	Hold	4,510	–	–	﹤0.01%	1468
2019 Q1	$87K	Hold	4,510	–	–	﹤0.01%	1433
2018 Q4	$65K	Hold	4,510	–	–	﹤0.01%	1422
2018 Q3	$94K	Hold	4,510	–	–	﹤0.01%	1408
2018 Q2	$107K	Buy	+4,510	New	+$90.6K	﹤0.01%	1393

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

QS Investors's IMMU Position: Q3 2020 in Review

QS Investors sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 4,510 shares — an estimated $160K sold.

QS Investors first reported a position in IMMU in Q2 2018 and held it in 9 quarters. The position peaked at $160K in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

QS Investors reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
QS Investors sold 4,510 Immunomedics Inc shares in Q3 2020, an estimated $160K.
QS Investors first reported a position in Immunomedics Inc in Q2 2018 and held it in 9 quarters.
QS Investors's Immunomedics Inc position peaked at $160K in Q2 2020.
408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.